NUVASIVE COROENT SYSTEM— 510(k) K071795

Name: FDA 510(k) clearance K071795
Creator: U.S. Food and Drug Administration
Published: 2007-12-04

Substantially Equivalent

Nuvasive, Inc.

FDA 510(k) clearance K071795 for NUVASIVE COROENT SYSTEM, Substantially Equivalent on 2007-12-04. Applicant: Nuvasive, Inc.. Device class: 2.

Clearance details

Applicant: Nuvasive, Inc.
Product code: Code MAX
Device class: Class 2
Regulation: 21 CFR 888.3080
Advisory panel: Orthopedic
Date received: 2007-07-02
Decision date: 2007-12-04
Decision: Substantially Equivalent
Clearance type: Abbreviated
Location: San Diego, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code MAX

view all

K261049 — SCALA® TL2026-08-20
K261430 — TruLift Expandable System2026-07-28
K253011 — Catalyft PL Expandable Interbody System2026-07-17
K261020 — Symmetrix L Spinal System2026-07-14
K253420 — Admiral ACP System +18 more2026-07-01

More clearances from Nuvasive, Inc.

view all

K240507 — NuVasive AttraX Scaffold2024-03-20
K223731 — NuVasive Modulus-C Interbody System2023-01-12
K211757 — Simplify Disc2021-08-20
K173117 — NuVasive® VersaTie System2017-12-07
K141665 — NuVasive CoRoent System2015-03-13

Adverse events under product code MAX

product code MAX

Death: 13
Injury: 1,305
Malfunction: 2,885
Total: 4,203

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.